Discovery Chemistry, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Bioorg Med Chem Lett. 2010 Dec 1;20(23):6969-74. doi: 10.1016/j.bmcl.2010.09.125. Epub 2010 Oct 21.
This study completes a series of papers devoted to the characterization of the non-competitive mGluR2/3 antagonist properties of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives with particular emphasis on derivatizations compatible with brain penetration and in vivo activity. Especially the compounds bearing a para-pyridine consistently showed in vivo activity in rat behavioral models after oral administration, for example, blockade of the mGluR2/3 agonist LY354740-induced hypoactivity and improvement of a working memory deficit induced either by LY354740 or scopolamine in the delayed match to position task (DMTP). Moreover, combination studies with a cholinesterase inhibitor show apparent synergistic effects on working memory impairment induced by scopolamine.
本研究完成了一系列致力于描述 1,3-二氢-苯并[b][1,4]二氮杂卓-2-酮衍生物的非竞争性 mGluR2/3 拮抗剂特性的论文,特别强调了与脑渗透和体内活性相容的衍生化。特别是,在口服给药后,具有对位吡啶的化合物在大鼠行为模型中始终表现出体内活性,例如,阻断 mGluR2/3 激动剂 LY354740 诱导的活动减退,以及改善由 LY354740 或东莨菪碱在位置延迟匹配任务 (DMTP) 中诱导的工作记忆缺陷。此外,与胆碱酯酶抑制剂的组合研究表明,对东莨菪碱诱导的工作记忆损伤具有明显的协同作用。